Literature DB >> 19574238

Comparison of long-term surgical success of Ahmed Valve implant versus trabeculectomy in open-angle glaucoma.

D H Tran1, C Souza, M J Ang, J Loman, S K Law, A L Coleman, J Caprioli.   

Abstract

AIM: To compare the long-term intraocular pressure (IOP) outcomes of Ahmed Glaucoma Valve (AGV) implantation to trabeculectomy with mitomycin C (MMC) in open-angle glaucoma (OAG).
METHODS: 78 OAG patients who underwent AGV implantation were matched with respect to age, preoperative surgery, preoperative IOP and preoperative medicines to 88 OAG patients who underwent trabeculectomy with MMC with a minimum of 3 years' follow-up. The cumulative probability of success between the two groups with different criteria was analysed: (1) an IOP < or =21 mm Hg and a reduction of IOP>/=15% from baseline; and (2) an IOP < or =18 mm Hg and a reduction of IOP > or =20% from baseline. No loss of light perception, no additional glaucoma surgery and no hypotony were also required.
RESULTS: The 5-year cumulative probability of success was not statistically significant between eyes that had an AGV or trabeculectomy with MMC when success was defined as criteria A (p = 0.094). However, when success was defined according to criteria B, eyes undergoing trabeculectomy with MMC had a higher rate of success (p = 0.024).
CONCLUSIONS: Trabeculectomy with MMC has a significantly higher 5-year cumulative probability of success compared with AGV implants when greater reduction IOP is necessary.

Entities:  

Mesh:

Year:  2009        PMID: 19574238     DOI: 10.1136/bjo.2008.150870

Source DB:  PubMed          Journal:  Br J Ophthalmol        ISSN: 0007-1161            Impact factor:   4.638


  19 in total

1.  Intraocular pressure control with Ahmed glaucoma drainage device in patients with cicatricial ocular surface disease-associated or aniridia-related glaucoma.

Authors:  Radwan Almousa; Damian B Lake
Journal:  Int Ophthalmol       Date:  2013-10-18       Impact factor: 2.031

Review 2.  Aqueous shunts for glaucoma.

Authors:  Victoria L Tseng; Anne L Coleman; Melinda Y Chang; Joseph Caprioli
Journal:  Cochrane Database Syst Rev       Date:  2017-07-28

3.  [Ahmed glaucoma valve via pars plana access. Long-term results of implantation for therapy refractive glaucoma].

Authors:  B Mazinani; H Schwarzer; A Willkomm; A Weinberger; N Plange; P Walter; G Rössler
Journal:  Ophthalmologe       Date:  2013-06       Impact factor: 1.059

4.  Efficacy of selective laser trabeculoplasty following incisional glaucoma surgery.

Authors:  Robert Allan Sharpe; Leah L Kammerdiener; David B Williams; Sudeep K Das; Matthew J Nutaitis
Journal:  Int J Ophthalmol       Date:  2018-01-18       Impact factor: 1.779

5.  Trabeculectomy with Ex-PRESS implant versus Ahmed glaucoma valve implantation-a comparative study.

Authors:  Michael Waisbourd; Naomi Fischer; Hadas Shalev; Oriel Spierer; Elad Ben Artsi; Rony Rachmiel; Gabi Shemesh; Shimon Kurtz
Journal:  Int J Ophthalmol       Date:  2016-10-18       Impact factor: 1.779

6.  Implantation of a second glaucoma drainage device.

Authors:  Brian A Francis; Rodrigo A B Fernandes; Handan Akil; Vikas Chopra; Bruno Diniz; James Tan; Alex Huang
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2017-02-07       Impact factor: 3.117

7.  The role of primary needle revision after Ahmed glaucoma valve (AGV) implantation.

Authors:  Maryam Yadgari; Kiana Hassanpour; Fatemeh Vafaei
Journal:  Int Ophthalmol       Date:  2020-08-27       Impact factor: 2.031

8.  Long-term results of Ahmed glaucoma valve implantation in Egyptian population.

Authors:  Eman Elhefney; Tharwat Mokbel; Waleed Abou Samra; Hanem Kishk; Tarek Mohsen; Amr El-Kannishy
Journal:  Int J Ophthalmol       Date:  2018-03-18       Impact factor: 1.779

9.  Surgical management of glaucoma: an Indian perspective.

Authors:  R Ramakrishnan; Mona Khurana
Journal:  Indian J Ophthalmol       Date:  2011-01       Impact factor: 1.848

10.  Long-term outcome of supraciliary gold micro shunt in refractory glaucoma.

Authors:  Michele Figus; Pasquale Loiudice; Andrea Passani; Laura Perciballi; Luca Agnifili; Marco Nardi; Chiara Posarelli
Journal:  Acta Ophthalmol       Date:  2021-07-27       Impact factor: 3.988

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.